10-K · March 11, 2026
Acme United positions itself as a leading supplier of first aid & medical products and cutting/sharpening tools, with first aid & medical growing to approximately 66% of sales. Net sales for 2025 were $196.5 million,…
Earnings analysis · 10-Q
ACU earnings analysis
Filed May 6, 2026 · Our reading of the company's report
The latest report
Acme United Corporation reported Q1 2026 net sales of $52.301 million, surpassing the consensus estimate of $48.9 million. However, diluted EPS of $0.24 fell significantly below the expected $0.43, marking a 41%…
Read full summary
Acme United Corporation reported Q1 2026 net sales of $52.301 million, surpassing the consensus estimate of $48.9 million. However, diluted EPS of $0.24 fell significantly below the expected $0.43, marking a 41% year-over-year decline. Increased costs related to tariffs and employee healthcare were cited as headwinds, while gross profit margins improved slightly to 39.7%.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
From revenue to operating profit
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $0.24
- Segment
- United States: $43,768,000, Canada: $3,700,000, Europe: $4,833,000
What stood out
-
Revenue Beat Consensus
Actual revenue was $52.301 million, beating the estimate of $48.9 million by approximately 6.4%.
-
Substantial Year-over-Year Growth
Revenue grew 14% year-over-year from $45.958 million in Q1 2025 to $52.301 million in Q1 2026.
-
Gross Margin Improvement
Gross margin increased to 39.7%, up from 39.0% in Q1 2025.
-
Strong Inventory Growth
Inventories grew from $59.852 million at December 31, 2025 to $63.386 million at March 31, 2026.
-
Increase in Receivables
Accounts receivable rose to $33.511 million, up from $29.098 million at year-end, reflecting stronger sales.
-
Progressive Reduction in Operating Loss
Operating income decreased to $1.746 million from $2.426 million in the prior year, but was in line with the revenue jump.
What to watch
-
Significant EPS Miss
Diluted EPS fell to $0.24, missing estimates by 44% and down from $0.41 a year ago.
-
Increased Operating Costs
SG&A expenses rose to $19.039 million from $15.491 million due to acquisition-related costs and higher personnel expenses.
-
Escalating Tariff Impact
Higher costs due to tariffs are expected to adversely affect margins as inventory subject to high 2025 tariffs was sold.
Management's outlook
Management did not provide specific forward guidance.
Earlier filings 4
10-Q · August 6, 2025
Acme United reported Q2 net sales of $53,996,000, down 3% versus $55,425,000 in Q2 2024, while gross margin expanded to 41.0% and operating income was essentially flat at $6,390,000. Diluted EPS was $1.16 (Q2 2025)…
10-Q · May 7, 2025
Acme United's Q1 2025 results showed a slight year-over-year revenue increase of 2% to $45.96 million, though they came in below consensus estimates. While gross margin improved slightly to 39%, diluted EPS dropped to…
10-K · March 6, 2025
Acme United reported 2024 net sales of $194.0 million and is emphasizing growth in its first aid & medical franchise (approximately 61% of sales in 2024) following the May 23, 2024 acquisition of Elite First Aid and…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.